At a glance
ClinicalIndex Comparison RecordN/ACompleted· 83 enrolled
Drug / intervention
Nelfilcon A multifocal contact lens with comfort additive +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Clinical Evaluation of the Safety and Efficacy of a New Multifocal Contact Lens
In Brief
A clinical study evaluating Nelfilcon A multifocal contact lens with comfort additive and Nelfilcon A multifocal contact lens for Myopia and 3 related conditions. Completed, enrolled 83 participants.
Detailed Summary
The purpose of this study was to demonstrate substantial equivalence of the new DAILIES® AquaComfort Plus® Multifocal (DACP MF) contact lens to the commercially available Focus® DAILIES® Progressives (FDP) contact lens.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsMyopia, Ametropia, Presbyopia, Refractive Error
Countries--
Collaborators--
Timeline
N/ACompletedFinished
20132014201520162017201820192020202120222023202420252026
Enrollment StartFeb 2013
First PostedFeb 2013
Primary CompletionApr 2013
TodayJul 2026
First PostedFeb 25, 2013
Enrollment StartFeb 1, 2013
Primary CompletionApr 1, 2013
TodayJul 2, 2026
Enrollment to primary: 2 monthsPosted 13.4 years ago
Interventions
Nelfilcon A multifocal contact lens with comfort additivedevice
Nelfilcon A multifocal contact lensdevice